Adding certolizumab pegol to background medication is better than adding a placebo for patients with active nonradiographic axial spondyloarthritis, according to a new study…
Hot Topics, Fresh Formats: ACR/ARP Annual Meeting Clinical Session Preview
The clinical sessions at the 2019 ACR/ARP Annual Meeting feature cutting-edge techniques in rheumatology and enable attendees to hone new skills and explore medically relevant topics…
From Climbing Walls to In the Rheum: What’s New at the 2019 Annual Meeting?
This year, the Annual Meeting Planning Committee has designed an engaging program, bringing together the best experts to address important topics. Here’s a sneak peek at what’s new…
Basic Science Sessions: Diverse Topics, Wide Appeal
Machine learning, immunology, the metabolism—are just a few of the topics addressed during…

All in One Setting: Integrated Team-Based Care for Autoimmunity
Rheumatologists, behavioral specialists, pharmacists and other healthcare professionals are working in the Autoimmunity Institute at Allegheny Health Network, Pittsburgh, to care for the whole patient…

Tanezumab’s Phase 3 Results for OA
In a recent study, tanezumab proved safe and effective in the treatment of knee and hip osteoarthritis…

The Rescue: Moving RA Patients from Adalimumab to Baricitinib
The phase 3, RA-BEAM study found RA patients who were switched from adalimumab to baricitinib experienced improvements in disease control even in the absence of an adalimumab washout. In the study, the change was not associated with an increase in adverse events or infections…
Medicare Patient Costs Lower at Teaching Hospitals
NEW YORK (Reuters Health)—The overall 30-day costs of caring for Medicare patients are lower at teaching hospitals, according to data from the Medicare inpatient file. “We found it really interesting that the lower costs seen at major teaching hospitals was driven primarily by lower costs after discharge from the hospital,” Dr. Laura G. Burke from…
Access 2020 Campaign Update
We are nearing the halfway point of 2019 and are one-quarter of the way through the ACR’s recently launched Access 2020 campaign, an advocacy campaign to increase ACR/ARP access to decision makers and the rulemaking process through RheumPAC by raising $300,000 and increasing the number of ACR/ARP members who contribute to 900. Progress Report So…

ACR Affiliate Society Council Spotlights State Efforts for Advocacy
So far it has been a busy year for the Affiliate Society Council (ASC). Forty-three states are now affiliated with the ACR through the ASC, and we may add another next year. Also, many state legislative sessions have wrapped up, so it’s a great time to provide an overview of the successes—and some of the…
- « Previous Page
- 1
- …
- 255
- 256
- 257
- 258
- 259
- …
- 814
- Next Page »